|High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis|
S Eyre, J Bowes, D Diogo, A Lee, A Barton, P Martin, A Zhernakova, ...
Nature genetics 44 (12), 1336, 2012
|Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial|
JD Leuppi, P Schuetz, R Bingisser, M Bodmer, M Briel, T Drescher, ...
Jama 309 (21), 2223-2231, 2013
|Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis|
G Palmer, D Talabot‐Ayer, C Lamacchia, D Toy, CA Seemayer, S Viatte, ...
Arthritis & rheumatism: official journal of the American College of …, 2009
|Genetics and epigenetics of rheumatoid arthritis|
S Viatte, D Plant, S Raychaudhuri
Nature Reviews Rheumatology 9 (3), 141, 2013
|Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway|
JC Lee, M Espéli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ...
Cell 155 (1), 57-69, 2013
|Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors|
DB Miklos, HT Kim, E Zorn, EP Hochberg, L Guo, A Mattes-Ritz, S Viatte, ...
Blood 103 (1), 353-359, 2004
|Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response|
S Viatte, D Plant, B Han, B Fu, A Yarwood, W Thomson, DPM Symmons, ...
Jama 313 (16), 1645-1656, 2015
|Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients|
S Viatte, D Plant, J Bowes, M Lunt, S Eyre, A Barton, J Worthington
Annals of the rheumatic diseases 71 (12), 1984-1990, 2012
|Adalimumab in severe and acute sciatica: A multicenter, randomized, double‐blind, placebo‐controlled trial|
S Genevay, S Viatte, A Finckh, P Zufferey, F Balagué, C Gabay
Arthritis & rheumatism 62 (8), 2339-2346, 2010
|Reverse immunology approach for the identification of CD8 T‐cell‐defined antigens: Advantages and hurdles|
S Viatte, PM Alves, P Romero
Immunology and cell biology 84 (3), 318-330, 2006
|Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer|
PMS Alves, N Lévy, H Bouzourene, S Viatte, G Bricard, M Ayyoub, ...
Cancer Immunology, Immunotherapy 56 (6), 839-847, 2007
|Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer|
PMS Alves, N Lévy, BJ Stevenson, H Bouzourene, G Theiler, G Bricard, ...
Cancer Immunity Archive 8 (1), 11, 2008
|Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome‐wide association study|
G Orozco, S Viatte, J Bowes, P Martin, AG Wilson, AW Morgan, S Steer, ...
Arthritis & Rheumatology 66 (1), 24-30, 2014
|Brief Report: Identification of BACH2 and RAD51B as Rheumatoid Arthritis Susceptibility Loci in a Meta‐Analysis of Genome‐Wide Data|
K McAllister, A Yarwood, J Bowes, G Orozco, S Viatte, D Diogo, ...
Arthritis & Rheumatism 65 (12), 3058-3062, 2013
|Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis|
ML Burr, S Viatte, M Bukhari, D Plant, DP Symmons, W Thomson, ...
Arthritis research & therapy 14 (3), R109, 2012
|Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial|
S Genevay, A Finckh, P Zufferey, S Viatte, F Balague, C Gabay
Annals of the rheumatic diseases 71 (4), 560-562, 2012
|Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage|
S Viatte, D Plant, M Lunt, B Fu, E Flynn, BJ Parker, J Galloway, ...
The Journal of rheumatology 40 (2), 144-156, 2013
|Genetics of rheumatoid arthritis susceptibility, severity, and treatment response|
S Viatte, A Barton
Seminars in immunopathology 39 (4), 395-408, 2017
|Replication of associations of genetic loci outside the hla region with susceptibility to anti–cyclic citrullinated peptide–negative rheumatoid arthritis|
S Viatte, J Massey, J Bowes, K Duffus, arcOGEN Consortium, S Eyre, ...
Arthritis & rheumatology 68 (7), 1603-1613, 2016
|HLA–DRB1 amino acid positions 11/13, 71, and 74 are associated with inflammation level, disease activity, and the health assessment questionnaire score in patients with …|
SF Ling, S Viatte, M Lunt, AM Van Sijl, L Silva‐Fernandez, DPM Symmons, ...
Arthritis & Rheumatology 68 (11), 2618-2628, 2016